// COMPANY
Sensible Biotechnologies
SECTOR BIOTECHMENTIONS 5LAST SEEN OCTOBER 11, 2026
// OVERVIEW
Cell-based mRNA manufacturing platform.
Discussed in
// RECENT MENTIONS
// SIGNALS
5 SIGNALS
01
funding·The VC Corner·OCTOBER 11, 2026
“Sensible Biotechnologies ($47M Series A, cell-based mRNA manufacturing platform)”
02
funding·StrictlyVC·OCTOBER 7, 2026
“Sensible Biotechnologies: It also secured up to $20 million in non-dilutive funding from the Government of Slovakia and the European Union. $27M Series A including In-Q-Tel.”
Source→03
funding·PitchBook News·OCTOBER 7, 2026
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.